Please login to the form below
Coronavirus vaccine
This page shows the latest Coronavirus vaccine news and features for those working in and with pharma, biotech and healthcare.
Merck ends its COVID-19 vaccine programme after disappointing early trial results
Merck &Co (MSD) has ended its COVID-19 vaccine programme after reviewing some disappointing phase 1 results for its candidates V590 and V591. ... We are grateful to our collaborators who worked with us on these vaccine candidates and to the volunteers in
Latest news
-
Moderna’s COVID-19 vaccine appears effective against UK and South Africa variants
Moderna has announced that its COVID-19 vaccine appears effective against new coronavirus variants discovered in the UK and South Africa (SA). ... BioNTech is also planning to publish an additional analysis of the vaccine's efficacy against the
-
Pfizer/BioNTech reach vaccine supply agreement with COVAX
Up to 40 million doses will be supplied to the international vaccine-sharing facility. ... Pfizer and BioNTech have agreed to supply up to 40 million doses of their COVID-19 vaccine to COVAX, the international vaccines-sharing facility.
-
Pfizer/BioNTech's COVID-19 vaccine found to be effective against UK virus variant
New results from a laboratory study of Pfizer/BioNTech’s COVID-19 vaccine have found that the vaccine should protect immunised individuals against the new coronavirus strain first identified in the ... BioNTech is also planning to publish an additional
-
EU proposes vaccine-sharing mechanism with low-income countries
The European Union is proposing the creation of a vaccine-sharing mechanism in order to deliver COVID-19 jabs to priority groups in low-income countries, according to the EU’s ... This week, WHO director-general Tedros Adhanom Ghebreyesus said that
-
J&J could launch its single-dose COVID-19 vaccine in March
US pharma Johnson &Johnson (J&J) is planning to launch its single-dose COVID-19 vaccine in March, according to the company’s chief scientific officer Paul Stoffels. . ... J&J previously signed an advance purchase agreement with the European Commission
More from news
Approximately 30 fully matching, plus 46 partially matching documents found.
Latest Intelligence
-
How will COVID-19 affect uptake of vaccinations against other diseases?
Coronavirus will be a blip on the horizon in comparison. The risk is trivial.”. ... Notably, Russia’s Sputnik V vaccine, developed by Moscow’s Gamaleya research centre, and announced by President Vladimir Putin in August as being the world’s
-
Multilingual remote conferencing and interpreting platforms in the era of COVID-19
The conference listings for 2020 were well established, but as the coronavirus became a more severe threat, the months of upfront planning were put on hold. ... In April this year there were 650 groups around the world carrying out 460 different
-
Developing a COVID-19 vaccine
GlaxoSmithKline has also partnered with Chinese biotech company Clover Biopharmaceuticals on a protein-based coronavirus vaccine candidate, named COVID-19 S-Trimer. ... Translate has already begun to produce multiple mRNA constructs and will use its
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Mistrust in medical research: a patient perspective
Health Products Regulatory Agency’s speedy approval of the Pfizer-BioNTech COVID-19 vaccine in the UK. ... The Thalidomide Society has said that comparisons between thalidomide and the COVID-19 vaccine are “insulting”.
-
Article: Pricing a coronavirus vaccine
Using findings from Research Partnership's recent COVID-19 impact study, Market Access Directors Rachel Howard and Brett Gardiner and Consultant Suzan Serip explore the challenges of pricing a coronavirus vaccine.
-
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it. ... Essentially, people with diabetes will remain at extreme risk, until a coronavirus vaccine becomes available and
-
Research Partnership
We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we provide custom solutions and strategic recommendations that go beyond research, helping our
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Account Director
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Medical Editor
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- Lilly’s antibody bamlanivimab cuts COVID-19 risk by up to 80%
- Pfizer/BioNTech reach vaccine supply agreement with COVAX
- AstraZeneca reduces initial COVID-19 vaccine deliveries to the EU
- AstraZeneca reduces initial COVID-19 vaccine deliveries to the EU
- Lilly’s antibody bamlanivimab cuts COVID-19 risk by up to 80%
- New study identifies drugs that are safe to use in COVID-19 treatment
- Regeneron’s antibody cocktail prevents COVID-19 in high-risk patients
- Moderna’s COVID-19 vaccine appears effective against UK and South Africa variants
- AZ refutes reports suggesting its COVID-19 vaccine is less effective in the elderly
- UK study finds antibiotics azithromycin and doxycycline ineffective against COVID-19
- Merck ends its COVID-19 vaccine programme after disappointing early trial results
- Wilmington Healthcare appoints new Head of Digital
PMHub
Lucid Group Communications Limited
WE’RE ON A MISSION
To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....
Latest intelligence
- An EU emergency health fund to limit the impact of future crises
- Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
Quick links
Infographics
